Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew P Martin

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Chemical Science|August 11, 2023
Fragment expansion with NUDELs - poised DNA-encoded librariesCatherine L A Salvini, Benoit Darlot, Jack Davison, et al.
Journal of Medicinal Chemistry|August 9, 2022
Build-Couple-Transform: A Paradigm for Lead-like Library Synthesis with Scaffold DiversityMélanie Uguen, Gemma Davison, Lukas J Sprenger, et al.
Communications Chemistry|April 9, 2025
Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent bindingPasquale A Morese, Ayaz Ahmad, Mathew P Martin, et al.
Journal of Medicinal Chemistry|January 26, 2012
Fragment-based and structure-guided discovery and optimization of Rho kinase inhibitorsRongshi Li, Mathew P Martin, Yan Liu, et al.
Journal of Medicinal Chemistry|March 13, 2019
FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit GenerationDaniel J Wood, J Daniel Lopez-Fernandez, Leanne E Knight, et al.
Organic & Biomolecular Chemistry|February 23, 2018
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approachDuncan C Miller, Mathew P Martin, Santosh Adhikari, et al.
Journal of Medicinal Chemistry|April 23, 2013
Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinasesErnst Schonbrunn, Stephane Betzi, Riazul Alam, et al.
Journal of Medicinal Chemistry|September 12, 2022
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid LeukemiaJosé Luis Marín-Rubio, Rachel E Peltier-Heap, Maria Emilia Dueñas, et al.
Journal of Medicinal Chemistry|August 30, 2023
Targeting Cytotoxic Agents through EGFR-Mediated Covalent Binding and ReleasePasquale A Morese, Nahoum Anthony, Michael Bodnarchuk, et al.
Journal of Medicinal Chemistry|November 11, 2022
Mapping Ligand Interactions of Bromodomains BRD4 and ATAD2 with FragLites and PepLites─Halogenated Probes of Druglike and Peptide-like Molecular InteractionsGemma Davison, Mathew P Martin, Shannon Turberville, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Chemical Science|August 11, 2023
Fragment expansion with NUDELs - poised DNA-encoded librariesCatherine L A Salvini, Benoit Darlot, Jack Davison, et al.
Journal of Medicinal Chemistry|August 9, 2022
Build-Couple-Transform: A Paradigm for Lead-like Library Synthesis with Scaffold DiversityMélanie Uguen, Gemma Davison, Lukas J Sprenger, et al.
Communications Chemistry|April 9, 2025
Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent bindingPasquale A Morese, Ayaz Ahmad, Mathew P Martin, et al.
Journal of Medicinal Chemistry|January 26, 2012
Fragment-based and structure-guided discovery and optimization of Rho kinase inhibitorsRongshi Li, Mathew P Martin, Yan Liu, et al.
Journal of Medicinal Chemistry|March 13, 2019
FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit GenerationDaniel J Wood, J Daniel Lopez-Fernandez, Leanne E Knight, et al.
Organic & Biomolecular Chemistry|February 23, 2018
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approachDuncan C Miller, Mathew P Martin, Santosh Adhikari, et al.
Journal of Medicinal Chemistry|April 23, 2013
Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinasesErnst Schonbrunn, Stephane Betzi, Riazul Alam, et al.
Journal of Medicinal Chemistry|September 12, 2022
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid LeukemiaJosé Luis Marín-Rubio, Rachel E Peltier-Heap, Maria Emilia Dueñas, et al.
Journal of Medicinal Chemistry|August 30, 2023
Targeting Cytotoxic Agents through EGFR-Mediated Covalent Binding and ReleasePasquale A Morese, Nahoum Anthony, Michael Bodnarchuk, et al.
Journal of Medicinal Chemistry|November 11, 2022
Mapping Ligand Interactions of Bromodomains BRD4 and ATAD2 with FragLites and PepLites─Halogenated Probes of Druglike and Peptide-like Molecular InteractionsGemma Davison, Mathew P Martin, Shannon Turberville, et al.
Pageof 4